EMAIL THIS PAGE TO A FRIEND

Parasites & vectors

Engineered single nucleotide polymorphisms in the mosquito MEK docking site alter Plasmodium berghei development in Anopheles gambiae.


PMID 24957684

Abstract

Susceptibility to Plasmodium infection in Anopheles gambiae has been proposed to result from naturally occurring polymorphisms that alter the strength of endogenous innate defenses. Despite the fact that some of these mutations are known to introduce non-synonymous substitutions in coding sequences, these mutations have largely been used to rationalize knockdown of associated target proteins to query the effects on parasite development in the mosquito host. Here, we assay the effects of engineered mutations on an immune signaling protein target that is known to control parasite sporogonic development. By this proof-of-principle work, we have established that naturally occurring mutations can be queried for their effects on mosquito protein function and on parasite development and that this important signaling pathway can be genetically manipulated to enhance mosquito resistance. We introduced SNPs into the A. gambiae MAPK kinase MEK to alter key residues in the N-terminal docking site (D-site), thus interfering with its ability to interact with the downstream kinase target ERK. ERK phosphorylation levels in vitro and in vivo were evaluated to confirm the effects of MEK D-site mutations. In addition, overexpression of various MEK D-site alleles was used to assess P. berghei infection in A. gambiae. The MEK D-site contains conserved lysine residues predicted to mediate protein-protein interaction with ERK. As anticipated, each of the D-site mutations (K3M, K6M) suppressed ERK phosphorylation and this inhibition was significant when both mutations were present. Tissue-targeted overexpression of alleles encoding MEK D-site polymorphisms resulted in reduced ERK phosphorylation in the midgut of A. gambiae. Furthermore, as expected, inhibition of MEK-ERK signaling due to D-site mutations resulted in reduction in P. berghei development relative to infection in the presence of overexpressed catalytically active MEK. MEK-ERK signaling in A. gambiae, as in model organisms and humans, depends on the integrity of conserved key residues within the MEK D-site. Disruption of signal transmission via engineered SNPs provides a purposeful proof-of-principle model for the study of naturally occurring mutations that may be associated with mosquito resistance to parasite infection as well as an alternative genetic basis for manipulation of this important immune signaling pathway.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4300493
Anti-MAPK3 (Ab-202) antibody produced in rabbit, affinity isolated antibody
SAB4300494
Anti-MAPK3 (Ab-204) antibody produced in rabbit, affinity isolated antibody
GW22781 Anti-MAPK3 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB1412386
ANTI-MAPK3 antibody produced in mouse, clone 1E2, purified immunoglobulin, buffered aqueous solution
SAB2701851
Anti-mapk3 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2701770
Anti-mapk3 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA003995
Anti-MAPK3 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA005700
Anti-MAPK3 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2104574
Anti-MAPK3 antibody produced in rabbit, affinity isolated antibody
SAB2104732
Anti-MAPK3 antibody produced in rabbit, affinity isolated antibody
M3946 Anti-MNK1 antibody produced in rabbit, ~1.4 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4503422
Anti-MNK1 antibody produced in rabbit, affinity isolated antibody
SAB4503423
Anti-MNK1 antibody produced in rabbit, affinity isolated antibody
SAB4502389
Anti-p44 MAP Kinase antibody produced in rabbit, affinity isolated antibody
SAB4502390
Anti-p44 MAP Kinase antibody produced in rabbit, affinity isolated antibody
M8159
Monoclonal Anti-MAP Kinase, Activated (Diphosphorylated ERK-1&2) antibody produced in mouse, clone MAPK-YT, ascites fluid
WH0005595M1
Monoclonal Anti-MAPK3 antibody produced in mouse, clone 3C9, purified immunoglobulin, buffered aqueous solution
SAB5300429
Monoclonal Anti-MAPK3 antibody produced in mouse, clone 1E5, ascites fluid
PLA0235
Rabbit anti-ERK1 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.